# Cell Reports Medicine

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/cell-reports-medicine/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 5,460 |
| Citations | 57,418 |
| h-index | 103 |
| Homepage | https://www.journals.elsevier.com/cell-reports-medicine |
| Open Access | true |
| ISSN-L | 2666-3791 |
| ISSNs | 2666-3791 |
| OpenAlex ID | https://openalex.org/S4210207453 |
| Publisher | Elsevier BV |
| Works | 2,198 |

## Journal papers

Showing 12 of 26.

- [The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19](https://scholariq.org/papers/the-il-1-il-6-and-tnf-cytokine-triad-is-associated-with-post-acute-sequelae-of/)
- [Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions](https://scholariq.org/papers/longitudinal-proteomic-analysis-of-severe-covid-19-reveals-survival-associated/)
- [Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike](https://scholariq.org/papers/cross-sectional-evaluation-of-humoral-responses-against-sars-cov-2-spike-2/)
- [Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells](https://scholariq.org/papers/pharmacological-inhibition-of-acid-sphingomyelinase-prevents-uptake-of-sars-cov/)
- [Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer](https://scholariq.org/papers/clonal-evolution-and-heterogeneity-of-osimertinib-acquired-resistance-mechanisms/)
- [Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study](https://scholariq.org/papers/using-patient-derived-organoids-to-predict-locally-advanced-or-metastatic-lung/)
- [Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant](https://scholariq.org/papers/rapid-decline-in-vaccine-boosted-neutralizing-antibodies-against-sars-cov-2-2/)
- [The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)](https://scholariq.org/papers/the-improbable-targeted-therapy-kras-as-an-emerging-target-in-non-small-cell/)
- [CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer](https://scholariq.org/papers/cxcl9-10-engineered-dendritic-cells-promote-t-cell-activation-and-enhance-immune/)
- [PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer](https://scholariq.org/papers/pd-l1-expressing-tumor-associated-macrophages-are-immunostimulatory-and/)
- [Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics](https://scholariq.org/papers/cancer-associated-fibroblasts-undergoing-neoadjuvant-chemotherapy-suppress/)
- [A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines](https://scholariq.org/papers/a-comparative-characterization-of-sars-cov-2-specific-t-cells-induced-by-mrna-or/)

## Journal top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.